Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Multi-Center, Open Label Trial to Establish the Therapeutic Equivalence Between GerEpo and Eprex® and to Determine the Long Term Safety Profile of GerEpo in Patients on Hemodialysis.

NCT00229099 is registered in ClinicalTrials.gov with Ministry of Health, Malaysia as lead sponsor.

NCT NCT00229099
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00229099 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Multi-Center, Open Label Trial to Establish the Therapeutic Equivalence Between GerEpo and Eprex® and to Determine the Long Term Safety Profile of GerEpo in Patients on Hemodialysis.
Lead sponsor
Ministry of Health, Malaysia
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2005
Completion date
November 30, 2005
Enrollment
270
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

chronic renal failure related anemia